Loading…

In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD)

By now, non-alcoholic fatty liver disease (NAFLD) is considered to be among the most common liver diseases world-wide. NAFLD encompasses a broad spectrum of pathological conditions ranging from simple steatosis to steatohepatitis, fibrosis and finally even cirrhosis; however, only a minority of pati...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2013-06, Vol.14 (6), p.11963-11980
Main Authors: Kanuri, Giridhar, Bergheim, Ina
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c547t-c3ee31919d4c83e5b2a93db1c824dd282f31e6232a64ddfa15f6348d5dfa38bc3
cites cdi_FETCH-LOGICAL-c547t-c3ee31919d4c83e5b2a93db1c824dd282f31e6232a64ddfa15f6348d5dfa38bc3
container_end_page 11980
container_issue 6
container_start_page 11963
container_title International journal of molecular sciences
container_volume 14
creator Kanuri, Giridhar
Bergheim, Ina
description By now, non-alcoholic fatty liver disease (NAFLD) is considered to be among the most common liver diseases world-wide. NAFLD encompasses a broad spectrum of pathological conditions ranging from simple steatosis to steatohepatitis, fibrosis and finally even cirrhosis; however, only a minority of patients progress to end-stages of the disease, and the course of the disease progression to the later stages seems to be slow, developing progressively over several years. Key risk factors including overweight, insulin resistance, a sedentary life-style and an altered dietary pattern, as well as genetic factors and disturbances of the intestinal barrier function have been identified in recent years. Despite intense research efforts that lead to the identification of these risk factors, knowledge about disease initiation and molecular mechanisms involved in progression is still limited. This review summarizes diet-induced and genetic animal models, as well as cell culture models commonly used in recent years to add to the understanding of the mechanisms involved in NAFLD, also referring to their advantages and disadvantages.
doi_str_mv 10.3390/ijms140611963
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_b0a1815ca3df46358eb5e9bd34ad4944</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_b0a1815ca3df46358eb5e9bd34ad4944</doaj_id><sourcerecordid>3308784221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c547t-c3ee31919d4c83e5b2a93db1c824dd282f31e6232a64ddfa15f6348d5dfa38bc3</originalsourceid><addsrcrecordid>eNpdkcFvFCEUh4nR2Fo9ejUkXuphFHjAwMWkqbbdZKMXPRMGmJYNM1SY3aT_vdStTbcn3oMvX368h9B7Sj4DaPIlbqZKOZGUagkv0DHljHWEyP7lk_oIval1QwgDJvRrdMSgBy17cYyuVjPexaVkbGeP432zy3jKPqSK84jnPHc2uXyTU3R4tMtyh1PchYJ9rMHWgE9_nF2sv316i16NNtXw7uE8Qb8vvv86v-rWPy9X52frzgneL52DEIBqqj13CoIYmNXgB-oU494zxUagQbacVrZ-tFSMErjyotWgBgcnaLX3-mw35rbEyZY7k200_y5yuTa2LNGlYAZiqaLCWfAjlyBUGETQgwduPdecN9fXvet2O0zBuzAvxaYD6eHLHG_Mdd4Z6InupWyC0wdByX-2oS5mitWFlOwc8rYaClJo1bdRN_TjM3STt2VuozJUMElaQKIa1e0pV3KtJYyPYSgx9_s2B_tu_IenP3ik_y8Y_gKna6V6</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1526046308</pqid></control><display><type>article</type><title>In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD)</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Kanuri, Giridhar ; Bergheim, Ina</creator><creatorcontrib>Kanuri, Giridhar ; Bergheim, Ina</creatorcontrib><description>By now, non-alcoholic fatty liver disease (NAFLD) is considered to be among the most common liver diseases world-wide. NAFLD encompasses a broad spectrum of pathological conditions ranging from simple steatosis to steatohepatitis, fibrosis and finally even cirrhosis; however, only a minority of patients progress to end-stages of the disease, and the course of the disease progression to the later stages seems to be slow, developing progressively over several years. Key risk factors including overweight, insulin resistance, a sedentary life-style and an altered dietary pattern, as well as genetic factors and disturbances of the intestinal barrier function have been identified in recent years. Despite intense research efforts that lead to the identification of these risk factors, knowledge about disease initiation and molecular mechanisms involved in progression is still limited. This review summarizes diet-induced and genetic animal models, as well as cell culture models commonly used in recent years to add to the understanding of the mechanisms involved in NAFLD, also referring to their advantages and disadvantages.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms140611963</identifier><identifier>PMID: 23739675</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>animal models ; Animals ; Animals, Genetically Modified ; Diet ; Disease Models, Animal ; Humans ; in vitro models ; insulin resistance ; non-alcoholic fatty liver disease ; Non-alcoholic Fatty Liver Disease - etiology ; Non-alcoholic Fatty Liver Disease - genetics ; Non-alcoholic Fatty Liver Disease - pathology ; Review</subject><ispartof>International journal of molecular sciences, 2013-06, Vol.14 (6), p.11963-11980</ispartof><rights>Copyright MDPI AG 2013</rights><rights>2013 by the authors; licensee MDPI, Basel, Switzerland 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c547t-c3ee31919d4c83e5b2a93db1c824dd282f31e6232a64ddfa15f6348d5dfa38bc3</citedby><cites>FETCH-LOGICAL-c547t-c3ee31919d4c83e5b2a93db1c824dd282f31e6232a64ddfa15f6348d5dfa38bc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1526046308/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1526046308?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,313,314,727,780,784,792,885,25753,27922,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23739675$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kanuri, Giridhar</creatorcontrib><creatorcontrib>Bergheim, Ina</creatorcontrib><title>In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD)</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>By now, non-alcoholic fatty liver disease (NAFLD) is considered to be among the most common liver diseases world-wide. NAFLD encompasses a broad spectrum of pathological conditions ranging from simple steatosis to steatohepatitis, fibrosis and finally even cirrhosis; however, only a minority of patients progress to end-stages of the disease, and the course of the disease progression to the later stages seems to be slow, developing progressively over several years. Key risk factors including overweight, insulin resistance, a sedentary life-style and an altered dietary pattern, as well as genetic factors and disturbances of the intestinal barrier function have been identified in recent years. Despite intense research efforts that lead to the identification of these risk factors, knowledge about disease initiation and molecular mechanisms involved in progression is still limited. This review summarizes diet-induced and genetic animal models, as well as cell culture models commonly used in recent years to add to the understanding of the mechanisms involved in NAFLD, also referring to their advantages and disadvantages.</description><subject>animal models</subject><subject>Animals</subject><subject>Animals, Genetically Modified</subject><subject>Diet</subject><subject>Disease Models, Animal</subject><subject>Humans</subject><subject>in vitro models</subject><subject>insulin resistance</subject><subject>non-alcoholic fatty liver disease</subject><subject>Non-alcoholic Fatty Liver Disease - etiology</subject><subject>Non-alcoholic Fatty Liver Disease - genetics</subject><subject>Non-alcoholic Fatty Liver Disease - pathology</subject><subject>Review</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkcFvFCEUh4nR2Fo9ejUkXuphFHjAwMWkqbbdZKMXPRMGmJYNM1SY3aT_vdStTbcn3oMvX368h9B7Sj4DaPIlbqZKOZGUagkv0DHljHWEyP7lk_oIval1QwgDJvRrdMSgBy17cYyuVjPexaVkbGeP432zy3jKPqSK84jnPHc2uXyTU3R4tMtyh1PchYJ9rMHWgE9_nF2sv316i16NNtXw7uE8Qb8vvv86v-rWPy9X52frzgneL52DEIBqqj13CoIYmNXgB-oU494zxUagQbacVrZ-tFSMErjyotWgBgcnaLX3-mw35rbEyZY7k200_y5yuTa2LNGlYAZiqaLCWfAjlyBUGETQgwduPdecN9fXvet2O0zBuzAvxaYD6eHLHG_Mdd4Z6InupWyC0wdByX-2oS5mitWFlOwc8rYaClJo1bdRN_TjM3STt2VuozJUMElaQKIa1e0pV3KtJYyPYSgx9_s2B_tu_IenP3ik_y8Y_gKna6V6</recordid><startdate>20130605</startdate><enddate>20130605</enddate><creator>Kanuri, Giridhar</creator><creator>Bergheim, Ina</creator><general>MDPI AG</general><general>Molecular Diversity Preservation International (MDPI)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20130605</creationdate><title>In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD)</title><author>Kanuri, Giridhar ; Bergheim, Ina</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c547t-c3ee31919d4c83e5b2a93db1c824dd282f31e6232a64ddfa15f6348d5dfa38bc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>animal models</topic><topic>Animals</topic><topic>Animals, Genetically Modified</topic><topic>Diet</topic><topic>Disease Models, Animal</topic><topic>Humans</topic><topic>in vitro models</topic><topic>insulin resistance</topic><topic>non-alcoholic fatty liver disease</topic><topic>Non-alcoholic Fatty Liver Disease - etiology</topic><topic>Non-alcoholic Fatty Liver Disease - genetics</topic><topic>Non-alcoholic Fatty Liver Disease - pathology</topic><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kanuri, Giridhar</creatorcontrib><creatorcontrib>Bergheim, Ina</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kanuri, Giridhar</au><au>Bergheim, Ina</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD)</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2013-06-05</date><risdate>2013</risdate><volume>14</volume><issue>6</issue><spage>11963</spage><epage>11980</epage><pages>11963-11980</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>By now, non-alcoholic fatty liver disease (NAFLD) is considered to be among the most common liver diseases world-wide. NAFLD encompasses a broad spectrum of pathological conditions ranging from simple steatosis to steatohepatitis, fibrosis and finally even cirrhosis; however, only a minority of patients progress to end-stages of the disease, and the course of the disease progression to the later stages seems to be slow, developing progressively over several years. Key risk factors including overweight, insulin resistance, a sedentary life-style and an altered dietary pattern, as well as genetic factors and disturbances of the intestinal barrier function have been identified in recent years. Despite intense research efforts that lead to the identification of these risk factors, knowledge about disease initiation and molecular mechanisms involved in progression is still limited. This review summarizes diet-induced and genetic animal models, as well as cell culture models commonly used in recent years to add to the understanding of the mechanisms involved in NAFLD, also referring to their advantages and disadvantages.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>23739675</pmid><doi>10.3390/ijms140611963</doi><tpages>18</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2013-06, Vol.14 (6), p.11963-11980
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_b0a1815ca3df46358eb5e9bd34ad4944
source Open Access: PubMed Central; Publicly Available Content Database
subjects animal models
Animals
Animals, Genetically Modified
Diet
Disease Models, Animal
Humans
in vitro models
insulin resistance
non-alcoholic fatty liver disease
Non-alcoholic Fatty Liver Disease - etiology
Non-alcoholic Fatty Liver Disease - genetics
Non-alcoholic Fatty Liver Disease - pathology
Review
title In vitro and in vivo models of non-alcoholic fatty liver disease (NAFLD)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T15%3A17%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vitro%20and%20in%20vivo%20models%20of%20non-alcoholic%20fatty%20liver%20disease%20(NAFLD)&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Kanuri,%20Giridhar&rft.date=2013-06-05&rft.volume=14&rft.issue=6&rft.spage=11963&rft.epage=11980&rft.pages=11963-11980&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms140611963&rft_dat=%3Cproquest_doaj_%3E3308784221%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c547t-c3ee31919d4c83e5b2a93db1c824dd282f31e6232a64ddfa15f6348d5dfa38bc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1526046308&rft_id=info:pmid/23739675&rfr_iscdi=true